High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulations, and increased R&D investments are key factors contributing to high CAGR of point of care diagnostics market during the forecast period.
According to the current analysis of Reports and Data, the global Leishmaniasis Treatment market was valued at USD 124.4 Million in 2020 and is expected to reach USD 237.7 Million by the year 2028, at a CAGR of 8.40%. A disease outbreak takes place when a disease escalates by a higher number than expected in a region or during a season. An outbreak may occur in one community or even extend to several countries altogether. There was a time when people in all countries and on all continents remain chronically vulnerable to infectious diseases, known and unknown. Leishmaniasis was the neglected tropical disease (NTD) that has threatened the people worldwide as per the WHO. Leishmaniasis is a major complex of protozoal vector-borne diseases that affects both humans and animals. The disease is caused by different species of Leishmania, and it is manifested by three major clinical forms named as cutaneous, mucosal and visceral leishmaniasis. Leishmaniasis is transmitted by the bite of infected female sand flies. In each of these forms, infection ranges from causing no symptoms (asymptomatic infection) to severe, even life-threatening complications.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2153
Market Dynamics:
The dynamics of pharma & healthcare industry has drastically changed, especially during the COVID-19 outbreak as the industry faced medication and hospital bed shortage, lack of skilled healthcare professionals and unavailability of sufficient funds. According to the latest report published by reports and data, the global Leishmaniasis Treatment market size is expected to reach over the forecast period. Revenue growth of the market is attributed to factors such as increasing prevalence of various diseases, improving healthcare and research infrastructure, high demand for vaccine and medicine and rapidly growing pharma and healthcare sector. Other factors such as availability of advanced treatment in many multispecialty health centers, and increasing awareness about early diagnosis and treatment. In addition, growing demand for precision medicine, increasing adoption of homecare settings and telemedicine, rising literacy rate around the globe and research and development investments for developing advanced drugs and devices are expected to fuel market going ahead.
The global Leishmaniasis Treatment market is extremely competitive and comprise various global and regional players. Sanofi S.A., Sequus Pharmaceuticals Inc., Paladin Labs Inc., Enzon Pharmaceuticals Inc., Gland Pharma Limited, Gilead Life sciences and Lifecare Innovations Private Limited.are some of the key players operating in the global market. These market players are various strategies such as mergers and acquisitions, collaborations, joint ventures, collaborations, partnerships and research and development investments to strengthen their market position and expand their product base.
Request a discount on the report @ https://www.reportsanddata.com/report-pricing/2153
For the purpose of this report, Reports and Data has segmented the global Leishmaniasis Treatment market on the basis of type, application and region:
Leishmaniasis Treatment Market segmentation by Types:
Disease Type (Revenue, USD Million; 2018–2028)
- Cutaneous Leishmaniasis
- Diffuse Cutaneous Leishmaniasis
- Mucocutaneous Leishmaniais
- Mucosal Leishmaniasis
- Visceral Leishmaniasis
Pathological tests (Revenue, USD Million; 2018–2028)
- By Serological Tests
- Direct Agglutination Test
- Indirect Immunofluorescent Antibody test (IFAT)
- Enzyme Linked Immunosorbent Assay (ELISA)
- Others
- Parasitological Evaluation
- Punch Biopsy
- Bone Marrow Biopsy
- Others
- DNA- Based Methods
- Nucleic Acid Hybridization
- Polymerase Chain Reaction (PCR)
- Immunological Methods
- Others
Therapy type (Revenue, USD Million; 2018–2028)
- By Drug Therapy
- Pentavalent Antimonials
- Sodium Stibogluconate
- SSG Meglumine antimoniate
- Antifungal
- Antibiotics
- Amphotericin B
- Liposomal amphotericin B
- Miltefosine
- Paromomycin
- Pentamidine
- By Non-Drug Therapy
- Cauterization
- Surgical Excision
- Cryotherapy
- Pentavalent Antimonials
End Use Revenue, USD Million; 2018–2028)
- Hospitals
- Clinics
- Diagnostic Laboratory
- Others
Regional Outlook of Leishmaniasis Treatment Market:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of APAC)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2153
Thank you for reading our research report. Kindly contact us to know more about the customization feature and plans and out team will help you with the best suited report as per your requirement.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]